Nav: Home

Acetaminophen: A viable alternative for preventing acute mountain sickness

June 19, 2017

Philadelphia, PA, June 19, 2017 - Trekking and mountain climbing are quickly growing in popularity, but.one of the challenges that climbers face is acute mountain sickness (AMS). Previous studies have shown that ibuprofen is an effective way to reduce the risk of AMS. Investigators wanted to find out if acetaminophen, a commonly used anti-pain medicine like ibuprofen, would have a comparable effect. They found almost no difference in the performance of both drugs, suggesting that acetaminophen may be another effective prophylactic treatment for AMS. Their results are published in Wilderness & Environmental Medicine.

AMS occurs when the body does not properly acclimatize to increasing elevation. The gold standard of prophylactic medication for AMS is acetazolamide, a prescription medication with distressing side effects like tingling and burning sensation (paresthesia), especially in the fingers and toes, and the risk of an allergic reaction. While ibuprofen had been shown to reduce the risk of AMS, it may have common unwanted side effects. Therefore, investigators wanted to assess whether acetaminophen, a popular and readily available drug similar in action to ibuprofen with fewer gastrointestinal side effects might also reduce the risk of AMS.

"The results of this study found no significant difference in the incidence and severity of AMS between prophylactic dosing of acetaminophen and ibuprofen," noted the study's lead investigator Buddha Basnyat, MD, from the Oxford University Clinical Research Unit, Kathmandu, Nepal, and the Himalayan Rescue Association and the Centre for Tropical Medicine and Global Health, University of Oxford, UK, and his co-investigators. "These results suggest that acetaminophen performs similar to ibuprofen in the prevention of AMS in partially-acclimatized subjects."

AMS is potentially deadly. The condition can often start out with symptoms normally associated with altitude sickness: headache, dizziness, fatigue, upset stomach, and poor sleep. If left untreated, AMS can progress and cause fatal neurologic or pulmonary conditions. "The best prevention of altitude illness is a slow ascent," explained Dr. Basnyat and his co-investigators. "However, proper acclimatization might be ignored or deemed impractical by mountain climbers, hikers, local pilgrims, rescue teams, or military operations."

A double-blind randomized trial followed 332 non-Nepali participants along the Everest trekking route. Subjects were recruited in both Pheriche (4371 m elevation) and Dingboche (4410 m) and instructed to take either acetaminophen or ibuprofen three times a day until they reached Lobuche (4940 m) where they were assessed using the Lake Louise Questionnaire, a well-established tool, to determine whether or not they had AMS. While some of the climbers did present with AMS at Lobuche, investigators found no statistically significant difference in the incidence and severity of AMS between the two groups.

"This finding suggests that the pathophysiology of AMS may not only be dependent on arachidonic-acid pathway and inflammation triggered by ibuprofen, but also other mechanisms that mediate nociception influenced by acetaminophen," concluded Dr. Basnyat and his co-investigators. "More studies need to be done, but this study clearly shows acetaminophen may be effective in the prevention of AMS and could be potentially useful for people who want an alternative drug to acetazolamide for the prevention of AMS."

"We appreciate the efforts of these investigators to evaluate questions that can impact the health and safety of many who journey into the high-altitude realm," stated Neal Pollock, PhD, editor-in-chief of Wilderness & Environmental Medicine, "and we are pleased to share the results with the community through the journal."
-end-


Elsevier

Related Acetaminophen Articles:

OHIO study: Acetaminophen can reduce positive empathy for others
A new study by an Ohio University faculty member showed that acetaminophen limited positive empathy a person has for others while taking it.
Scientists find new therapy target for drug-induced liver failure
Acetaminophen -- a commonly used pain reliever and fever reducer -- is the leading cause of quickly developing, or acute, liver failure in the U.S.
Acetaminophen may increase stroke risk for those with diabetes
Surprisingly, we are only now coming to understand how acetaminophen works -- and recent research shows that we may need to develop a better understanding of the need for caution when using acetaminophen, especially when it comes to avoiding some of the risks associated with its use.
Study finds IV and pill form of acetaminophen work equally well after hip replacement
Pain management after surgery is a vital part of patient care.
Drug interactions in ER's common but preventable, Rutgers study finds
In a recent Rutgers study, 38 percent of patients discharged from the emergency department had at least one drug interaction resulting from a newly prescribed medicine.
More Acetaminophen News and Acetaminophen Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...